Abstract
Objective: To observe the analgesic effect of combined spinal and epidural anesthesia on older patients undergoing hip fracture surgery. Method: One hundred and twenty elderly hip fracture surgery patients treated in our hospital from January 2021 to December 2022 were selected and randomly divided into two groups, with 60 cases in the experimental group and 60 in the control group. The experimental group was given combined spinal-epidural anesthesia intervention measures, while the control group was given epidural anesthesia intervention measures. The analgesic effect, tumor necrosis factor-alpha (TNF-α), C-reactive protein (CRP) levels, and other observation indicators were analyzed after anesthesia intervention. Result: After the intervention, the analgesic effect and the evaluation results of the subjects in the experimental group were better than those in the control group (P < 0.05); the obtained values of TNF-α and CRP levels in the experimental group were significantly lower than those of the control group (P < 0.05). Conclusion: The combined spinal-epidural anesthesia intervention demonstrated positive outcomes. The analgesic effect of patients during surgery and their inflammatory factor levels improved, which makes this intervention worthy of clinical application and promotion.
Introduction
Hip fractures in the elderly represent a significant clinical challenge, primarily due to age-related declines in bone density and physical stability. While surgical intervention is the standard of care, the anesthetic management of these patients is complicated by comorbidities—such as cardiovascular, hepatic, or renal dysfunction—and physiological changes like intervertebral foraminal occlusion. Traditional epidural anesthesia (EA) often presents with a slow onset and inconsistent analgesic effects in this population. This study investigates whether combined spinal-epidural anesthesia (CSEA) can provide more reliable pain management and mitigate the systemic inflammatory response triggered by surgery.
Methods
A randomized controlled trial was conducted involving 120 elderly patients (ages 70–91) at the Affiliated Hospital of Shandong Second Medical University between 2021 and 2022. Patients were divided into two groups of 60:
- Control Group (EA): Received standard epidural anesthesia using 1.5% lidocaine.
- Experimental Group (CSEA): Received a combined approach involving a spinal injection of 0.75% bupivacaine mixed with 5% glucose, followed by epidural catheterization for continuous management.
Primary outcomes included analgesic efficacy, measured via the Pain Numerical Rating Scale (NRS) at 8, 12, and 24 hours post-surgery, and the inflammatory response, assessed through blood levels of Tumor Necrosis Factor-alpha (TNF-α) and C-reactive protein (CRP).
Results
The experimental (CSEA) group demonstrated statistically significant improvements over the control group across all primary metrics ($P < 0.05$).
Analgesic Efficacy
The CSEA group reported consistently lower pain scores at all post-operative intervals. Notably, at 24 hours post-operation, the CSEA group had a mean NRS score of 1.60, compared to 2.19 in the EA group.
Inflammatory Response
Surgical trauma typically induces a systemic inflammatory response. However, the CSEA group exhibited significantly lower levels of pro-inflammatory markers compared to the control group, suggesting that the more effective neural block provided by CSEA inhibits the release of these cytokines.
Discussion and Conclusion
The findings suggest that CSEA offers a "best of both worlds" approach for elderly hip fracture patients, combining the rapid onset and muscle relaxation of spinal anesthesia with the prolonged management capabilities of an epidural. Beyond superior pain relief, the reduction in TNF-α and CRP levels indicates a more stable biochemical environment post-surgery, which may facilitate smoother recovery and fewer systemic complications.
While the study is limited by its single-center design and relatively small sample size, the results strongly support the clinical application of CSEA in this demographic. Future multi-center studies should focus on long-term recovery trajectories and mortality rates to further validate these benefits.
Summary updated